IRIS
DUMINUCO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 640
EU - Europa 552
AS - Asia 297
AF - Africa 109
SA - Sud America 52
OC - Oceania 4
Totale 1.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 631
IT - Italia 425
SG - Singapore 209
CI - Costa d'Avorio 82
CN - Cina 73
IE - Irlanda 51
BR - Brasile 50
SN - Senegal 20
FI - Finlandia 19
BE - Belgio 8
DE - Germania 8
UA - Ucraina 8
FR - Francia 7
HK - Hong Kong 6
CZ - Repubblica Ceca 5
NL - Olanda 5
RU - Federazione Russa 5
AU - Australia 4
MX - Messico 4
NG - Nigeria 4
CA - Canada 3
GB - Regno Unito 3
IN - India 3
SE - Svezia 3
IQ - Iraq 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HR - Croazia 1
JP - Giappone 1
KE - Kenya 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
SI - Slovenia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 1.654
Salva come PNG Salva come JPEG
Città #
Santa Clara 229
Singapore 150
Chicago 111
Abidjan 82
Catania 63
Ashburn 52
Dublin 49
Civitanova Marche 48
Chandler 43
Boardman 38
Rome 36
Milan 25
Hefei 24
Dakar 20
Palermo 19
Florence 11
Los Angeles 11
Lappeenranta 10
Helsinki 9
Misterbianco 9
Bronte 8
Brussels 8
Messina 8
Turin 8
Cambridge 6
Hong Kong 6
Lawrence 6
Washington 6
Cassano delle Murge 5
Naples 5
Piazzola Sul Brenta 5
San Giovanni la Punta 5
Abuja 4
Bari 4
Brno 4
Genoa 4
Paris 4
Aci Sant'Antonio 3
Amsterdam 3
Belo Horizonte 3
Frankfurt am Main 3
Lamezia Terme 3
Melbourne 3
Munich 3
Piacenza 3
Rio de Janeiro 3
Santa Venerina 3
Örebro 3
Acireale 2
Ancona 2
Andover 2
Campinas 2
Caselle Torinese 2
Cernusco sul Naviglio 2
Cornaredo 2
Council Bluffs 2
Galloway 2
Lonigo 2
Melilli 2
Mexico City 2
New York 2
Orvieto 2
Paternò 2
Pedara 2
Ribeirão Preto 2
Seattle 2
Trecastagni 2
Veracruz 2
Aci Castello 1
Aci Catena 1
Araruna 1
Armação dos Búzios 1
Asunción 1
Augusta 1
Baghdad 1
Barcellona Pozzo di Gotto 1
Barro Alto 1
Beijing 1
Bernareggio 1
Brasília 1
Bremen 1
Campo Grande 1
Capão da Canoa 1
Cascina del Sole 1
Catanduva 1
Chelyabinsk 1
Chongqing 1
Cosenza 1
Cotia 1
Criciúma 1
Curitiba 1
Dalian 1
Des Moines 1
Diamante do Norte 1
Easton 1
Elesbão Veloso 1
Erbil 1
Floridia 1
Foggia 1
Fort St. James 1
Totale 1.240
Salva come PNG Salva come JPEG
Nome #
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 88
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 78
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 78
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 66
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients 64
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 61
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 60
Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field 58
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases 57
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project 56
Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology 55
Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters 53
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 52
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 51
VEXAS-like syndrome: a potential new entity? 51
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study 47
A case of high-risk AML in a patient with advanced systemic mastocytosis 45
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 44
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 43
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 42
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes 42
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 39
Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association 39
Leishmania Infection during Ruxolitinib Treatment: The Cytokines-Based Immune Response in the Setting of Immunocompromised Patients 38
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study 38
Renal extramedullary hematopoiesis as an epiphenomenon of bone marrow dysfunction in a patient with primary myelofibrosis: A rare case report 36
Multicentric Castleman disease and concurrent hematological disorders: the occurrence of plasmacytoma and the hypotheses arising from literature's review 35
AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib 34
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 33
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy 31
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 30
Myelofibrosis: In Search for BETter Targeted Therapies 24
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 23
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases 23
Transient Leukemoid Reaction from T-Cell Large Granular Lymphocytes Post Autologous Stem Cell Transplant in a Patient Affected by Hodgkin Lymphoma 22
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey 13
Emergencies in Hematology: Why, When and How I Treat? 11
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease 11
Occurrence of lymphoproliferative disorders during ruxolitinib treatment: May fedratinib be the turning point? 10
Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms 6
Clinical outcomes of ruxolitinib treatment in 595 intermediate‐1 risk patients with myelofibrosis: The RUX‐MF Real‐World Study 5
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib 5
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 4
Totale 1.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202252 0 0 0 0 6 4 3 1 6 14 5 13
2022/2023230 7 15 5 12 12 20 7 43 51 14 34 10
2023/2024474 26 60 22 55 13 88 33 36 6 17 80 38
2024/2025945 16 174 41 114 190 121 60 45 71 85 28 0
Totale 1.701